Rain Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Net Income	-72.26	-75.72	-51.39	-21.08	-10.9
Depreciation & Amortization	0.21	0.08	0.07	0.05	0.03
Share-Based Compensation	4.9	4.86	3.09	0.87	0.24
Other Operating Activities	1.4	7.59	10.77	8.94	-0.54
Operating Cash Flow	-65.76	-63.2	-37.46	-11.23	-11.18
Capital Expenditures	-0.69	-0.01	-0.13	-0.02	-0.14
Acquisitions	-2	0	-2.5	-5.17	0
Change in Investments	12.84	47.2	-115.61	0	0
Investing Cash Flow	10.15	47.19	-118.24	-5.19	-0.14
Share Issuance / Repurchase	53.09	53.18	133.49	0.05	0
Debt Issued / Paid	0	0	0	6.44	2.5
Other Financing Activities	-	-	-11.87	63.01	-
Financing Cash Flow	53.09	53.18	121.62	69.49	2.5
Net Cash Flow	-2.52	37.18	-34.08	53.07	-8.83
Free Cash Flow	-66.45	-63.21	-37.59	-11.26	-11.33
Free Cash Flow Per Share	-1.83	-2.26	-1.94	-3.36	-4.68

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).